HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
Rain Therapeutics Inc. is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology. Rain’s lead product candidate, RAIN-32 (milademetan, formerly known as DS-3032), is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to RAIN-32, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.
| Market Cap | 331.893 Million | Shares Outstanding | 26.467 Million | Avg 30-day Volume | 78.201 Thousand | ||
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | 0 | ||
| Price/Sales | Debt to Equity | EBITDA | |||||
| Price to Book Value | 0.0 | Forward PE | -6.29 | Enterprise Value | |||
| Total Cash | Current Debt | Gross Profit | |||||
| BETA | 0.0 | 52-week High/Low | 23.9 / 12.45 | Next Earnings Date | 2021-11-11 | Price to Cash FLow (P/CF) | -9999999.0 |
| Data provided by IEX Cloud | |||||||
Please sign in first
407.1 Thousand total shares from 7 transactions
50 Thousand total shares from 7 transactions
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
2,487,019 | 2021-10-07 | 2 | |
|
BIOTECHNOLOGY VALUE FUND II LP |
|
6,308,720 | 2021-09-21 | 9 |
|
840,326 | 2021-09-21 | 3 | |
|
24,000 | 2021-05-14 | 1 | |
|
CABATUAN NELSON SEE REMARKS |
|
6,000 | 2021-05-12 | 1 |
|
CORMORANT ASSET MANAGEMENT, LP CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP |
|
No longer subject to file | 2021-04-27 | 1 |
|
8,796 | 2021-04-27 | 1 | |
|
DOEBELE ROBERT EVP, CHIEF SCIENTIFIC OFFICER |
|
467,937 | 2021-04-27 | 1 |
|
VELLANKI AVANISH PRESIDENT AND CEO |
|
2,511,442 | 2021-04-27 | 1 |
|
4,277,215 | 2021-04-23 | 1 | |
|
4,277,215 | 2021-04-23 | 1 |
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 22:15:04 UTC | -1.4297 | 1.4997 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 21:45:03 UTC | -1.4297 | 1.4997 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 21:15:03 UTC | -1.4297 | 1.4997 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 20:45:03 UTC | -1.4071 | 1.4771 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 20:15:03 UTC | -1.4071 | 1.4771 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 19:45:03 UTC | -1.4071 | 1.4771 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 19:15:04 UTC | -1.4071 | 1.4771 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 18:45:03 UTC | -1.6266 | 1.6966 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 18:15:03 UTC | -1.6266 | 1.6966 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 17:45:03 UTC | -1.6266 | 1.6966 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 17:15:03 UTC | -1.6266 | 1.6966 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 16:45:03 UTC | -1.6204 | 1.6904 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 16:15:03 UTC | -1.6204 | 1.6904 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 15:45:03 UTC | -1.6204 | 1.6904 | 20000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 15:15:03 UTC | -1.6204 | 1.6904 | 10000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 14:45:02 UTC | -1.7282 | 1.7982 | 10000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 14:15:03 UTC | -1.7282 | 1.7982 | 10000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 13:45:03 UTC | -1.7282 | 1.7982 | 10000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 13:15:03 UTC | -1.7282 | 1.7982 | 10000 |
| RAIN THERAPEUTICS INC RAIN | 2021-10-15 12:45:03 UTC | -1.7282 | 1.7982 | 10000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|---|---|---|---|
| Weiss Strategic Interval Fund- Weiss Strategic Interval Fund | RAIN | -720.0 shares, $-11188.8 | 2021-06-30 | N-PORT |
| Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund | RAIN | -79.0 shares, $-1315.35 | 2021-07-31 | N-PORT |
